However, we found a suggestive positive association of genetically predicted IGF‐1 levels with prostate cancer in UK Biobank (OR 1.10; P = .04) and a similar non‐significant estimate in the Biobank Japanese Project (OR 1.08; P = .24). The gene discussed is IGF1; the disease is Familial prostate cancer.